Business Context and Reporting Period
The filing is an unaudited Form 10-Q for II-VI Incorporated, not Coherent Corp. It covers the quarter and nine months ended March 31, 2017, within fiscal 2017. II-VI develops and manufactures engineered materials, photonic and optoelectronic components for industrial, optical communications, military, semiconductor, medical and consumer applications. The company reports three segments: II-VI Laser Solutions, II-VI Photonics and II-VI Performance Products.
The requested metadata identifies “Coherent Corp.” and “2016 Q3,” which does not match the filing text. The filing was signed May 2, 2017.
Key Financial Metrics
| Metric | Three Months Ended March 31 | Nine Months Ended March 31 |
|---|---|---|
| Revenue | $245.0 million, up 19% | $698.3 million, up 19% |
| Gross margin | $97.7 million; 39.9% versus 37.9% | $279.5 million; 40.0% versus 37.6% |
| Earnings before taxes | $29.3 million versus $17.4 million | $84.9 million versus $61.7 million |
| Net earnings | $22.4 million versus $14.9 million | $62.6 million versus $51.1 million |
| Diluted EPS | $0.35 versus $0.24 | $0.97 versus $0.81 |
| Net margin | 9.1% versus 7.3% | 9.0% versus 8.7% |
| Bookings | $280.8 million, up 19% | $799.4 million, up 27% |
International revenue was $164.0 million in the quarter and $473.9 million year to date, compared with $130.2 million and $365.9 million, respectively, in the prior-year periods. The effective tax rate for the nine-month period was 26.3%, compared with 17.1% in the prior year.
- Operating cash flow: $78.4 million for the first nine months, versus $81.2 million in the prior year.
- Capital expenditures: $99.1 million, versus $32.7 million, reflecting increased investment in optoelectronic manufacturing capacity.
- Cash and equivalents: $247.6 million at March 31, 2017, versus $218.4 million at June 30, 2016.
- Total debt: $279.7 million, versus $235.9 million at June 30, 2016; debt included $187.0 million under a revolving facility, a $90.0 million term loan and $2.7 million of Yen-denominated borrowings.
- Liquidity: $138.4 million of available borrowing capacity, net of applicable reductions for letters of credit.
- Working capital: Accounts receivable increased to $173.6 million and inventories to $191.8 million from $164.8 million and $175.1 million, respectively, at June 30, 2016.
Material Changes Versus the Prior Comparable Period
- Revenue growth was driven primarily by optical communications demand related to China broadband expansion, data-center and U.S. metro upgrade cycles, as well as demand for CO2 and one-micron laser applications.
- Gross margin improved due to operating leverage and favorable product mix, particularly in II-VI Photonics.
- Internal research and development increased to $25.4 million in the quarter and $70.8 million year to date, compared with $14.9 million and $40.3 million, respectively. Management attributed the increase to VCSEL development, new optoelectronic devices and other growth initiatives.
- SG&A declined slightly in the quarter and increased modestly year to date, while its percentage of revenue improved due to acquisition synergies and operating leverage.
- Interest and other, net changed from expense of $2.1 million to income of $0.2 million in the quarter and from expense of $1.2 million to income of $5.1 million year to date. The current-year benefit included foreign-currency gains, income from residual agreements related to the sale of the ANADIGICS RF business and a gain on the sale of a Florida facility.
- II-VI Photonics was the strongest segment, with quarterly revenue up 35% and operating income up 66%; nine-month revenue increased 35% and operating income increased 96%.
- II-VI Laser Solutions revenue increased 13% for both periods. Quarterly operating income increased 54%, but nine-month operating income decreased 22%, reflecting operating losses from the recently acquired EpiWorks and ANADIGICS businesses.
- II-VI Performance Products revenue increased 3% for both periods, while operating income increased 9% for the quarter and 6% year to date.
Guidance, Outlook, Risks and Unusual Items
Management did not provide specific numerical revenue or earnings guidance in the filing. Management stated that internal research and development expense as a percentage of revenue was expected to remain near the current run rate as the company continued investing in its high-volume VCSEL platform. Management also stated that operating cash flow, cash reserves and available borrowing capacity were expected to fund working capital, capital expenditures, debt repayments, capital lease obligations, research and development, share repurchases and growth objectives for the next twelve months.
- The amended credit facility provides a $325 million revolving facility and a $100 million term loan, maturing July 27, 2021. The company was in compliance with its financial covenants at March 31, 2017.
- The company entered into a $25.0 million capital lease for a New Jersey facility, recorded a $23.7 million long-term capital lease obligation, and has total contractual obligations of approximately $431.0 million.
- The EpiWorks contingent earnout liability was $5.5 million at March 31, 2017, with up to $6.0 million of additional cash payments possible based on specified performance targets.
- Unrecognized income tax benefits were $6.6 million. Certain U.S., state and foreign tax years remain open to examination.
- Key disclosed risks include international operations and foreign exchange, rapidly changing technology, new-product acceptance, supply-chain issues, competition, intellectual-property protection, acquisitions and integration, goodwill or intangible impairment, regulation, data breaches, natural disasters and customer purchasing patterns.
- Foreign currency forward contracts had a $7.9 million notional amount at March 31, 2017. A 1% increase in interest rates would have increased interest expense by approximately $0.4 million for the quarter and $1.3 million for the nine-month period.
- Management concluded that disclosure controls were effective and that no material changes occurred in internal control over financial reporting.
Most Important Facts to Verify
- Confirm the intended issuer and period: the supplied filing is II-VI Incorporated for the quarter ended March 31, 2017, not Coherent Corp. for 2016 Q3.
- Assess whether the substantial increase in capital expenditures is producing the expected VCSEL and optoelectronic manufacturing capacity and returns.
- Monitor acquisition-related losses in II-VI Laser Solutions, especially EpiWorks and ANADIGICS integration and performance.
- Evaluate liquidity after considering $279.7 million of debt, $24.7 million of capital lease obligations, scheduled debt amortization and approximately $99.1 million of year-to-date capital expenditures.
- Review the sustainability of optical communications demand, China broadband activity, data-center investment and U.S. metro upgrade cycles.
- Verify the impact of the higher effective tax rate, U.S. valuation allowance and foreign earnings reinvestment strategy.
- Review contingent earnouts, tax exposures, warranty obligations, foreign-exchange sensitivity and the contractual-obligation schedule.